Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rabinovitz, Mordechai
ARGON-2, NCT04378010 / 2019-003876-38: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH	Terminated	2b	98	Europe, Canada, US, RoW	EDP-305 1.5 mg, EDP-305, EDP-305 2 mg, Placebo	Enanta Pharmaceuticals, Inc, Enanta Pharmaceuticals, Inc.	Non-Alcoholic Steatohepatitis	10/21	11/21
PACIFIC, NCT05525520 / 2021-002526-25: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis	Completed	2	62	Europe, Canada, US, RoW	EP547, Placebo	Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc.	Pruritus	07/24	09/24
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)	Recruiting	2	200	Europe, Canada, US, RoW	Volixibat, SHP626, Placebo	Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.	Primary Sclerosing Cholangitis	09/25	12/25
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects	Recruiting	2	240	US, RoW	HM15211, Placebo of HM15211	Hanmi Pharmaceutical Company Limited	NASH - Nonalcoholic Steatohepatitis	05/26	11/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH	Active, not recruiting	2	271	Europe, Canada, Japan, US, RoW	GSK4532990, Placebo	GlaxoSmithKline, GlaxoSmithKline Research & Development Limited	Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease	12/25	03/26